Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
0019-4964
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review ; day:9 ; month:2 ; year:2023 ; pages:1-14
Journal of the Indian Institute of Science / Indian Institute of Science ; (9.2.2023), 1-14
- Creator
-
Hickman, Elizabeth
Gillies, Clare
Khunti, Kamlesh
Seidu, Samuel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41745-022-00352-7
- URN
-
urn:nbn:de:101:1-2023041321232371694580
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hickman, Elizabeth
- Gillies, Clare
- Khunti, Kamlesh
- Seidu, Samuel
- SpringerLink (Online service)
Other Objects (12)
Deprescribing in cardiometabolic conditions in older patients: a systematic review
Diabetes and the COVID-19 pandemic
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Polypharmacy and deprescribing: challenging the old and embracing the new
Towards a Prescription for Change: Interprofessional Management of Polypharmacy and Deprescribing
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Introduction: Real-World Evidence in Type 2 Diabetes
Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study
Deprescribing in cardiometabolic conditions in older patients: a systematic review
Diabetes and the COVID-19 pandemic
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Polypharmacy and deprescribing: challenging the old and embracing the new
Towards a Prescription for Change: Interprofessional Management of Polypharmacy and Deprescribing
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Introduction: Real-World Evidence in Type 2 Diabetes
Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study
Deprescribing in cardiometabolic conditions in older patients: a systematic review
Diabetes and the COVID-19 pandemic
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Polypharmacy and deprescribing: challenging the old and embracing the new
Towards a Prescription for Change: Interprofessional Management of Polypharmacy and Deprescribing
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Introduction: Real-World Evidence in Type 2 Diabetes